Report Cover

Global and United States Urology Drugs Market Report & Forecast 2022-2028


Urology Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Urology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Urology Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
    ?? (alpha) Blockers
    5 ??-reductase Inhibitors
Segment by Application
    Hospital
    Clinic
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Astellas
    Endo
    GP Pharm
    Tolmar
1 Study Coverage
    1.1 Urology Drugs Product Introduction
    1.2 Global Urology Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Urology Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Urology Drugs Sales in Volume for the Year 2017-2028
    1.3 United States Urology Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Urology Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Urology Drugs Sales in Volume for the Year 2017-2028
    1.4 Urology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Urology Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Urology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Urology Drugs Market Dynamics
        1.5.1 Urology Drugs Industry Trends
        1.5.2 Urology Drugs Market Drivers
        1.5.3 Urology Drugs Market Challenges
        1.5.4 Urology Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Urology Drugs Market Segment by Type
        2.1.1 ?? (alpha) Blockers
        2.1.2 5 ??-reductase Inhibitors
    2.2 Global Urology Drugs Market Size by Type
        2.2.1 Global Urology Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Urology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Urology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Urology Drugs Market Size by Type
        2.3.1 United States Urology Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Urology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Urology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Urology Drugs Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Urology Drugs Market Size by Application
        3.2.1 Global Urology Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Urology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Urology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Urology Drugs Market Size by Application
        3.3.1 United States Urology Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Urology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Urology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Urology Drugs Competitor Landscape by Company
    4.1 Global Urology Drugs Market Size by Company
        4.1.1 Top Global Urology Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Urology Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global Urology Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global Urology Drugs Price by Manufacturer (2017-2022)
    4.2 Global Urology Drugs Concentration Ratio (CR)
        4.2.1 Urology Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Urology Drugs in 2021
        4.2.3 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Urology Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global Urology Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Urology Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into Urology Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Urology Drugs Market Size by Company
        4.5.1 Top Urology Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Urology Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Urology Drugs Sales by Players (2020, 2021 & 2022)
5 Global Urology Drugs Market Size by Region
    5.1 Global Urology Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Urology Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global Urology Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global Urology Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Urology Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global Urology Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global Urology Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Urology Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Urology Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Urology Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Urology Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Urology Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Urology Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Astellas
        7.1.1 Astellas Corporation Information
        7.1.2 Astellas Description and Business Overview
        7.1.3 Astellas Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Astellas Urology Drugs Products Offered
        7.1.5 Astellas Recent Development
    7.2 Endo
        7.2.1 Endo Corporation Information
        7.2.2 Endo Description and Business Overview
        7.2.3 Endo Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Endo Urology Drugs Products Offered
        7.2.5 Endo Recent Development
    7.3 GP Pharm
        7.3.1 GP Pharm Corporation Information
        7.3.2 GP Pharm Description and Business Overview
        7.3.3 GP Pharm Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 GP Pharm Urology Drugs Products Offered
        7.3.5 GP Pharm Recent Development
    7.4 Tolmar
        7.4.1 Tolmar Corporation Information
        7.4.2 Tolmar Description and Business Overview
        7.4.3 Tolmar Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Tolmar Urology Drugs Products Offered
        7.4.5 Tolmar Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Urology Drugs Industry Chain Analysis
    8.2 Urology Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Urology Drugs Distributors
    8.3 Urology Drugs Production Mode & Process
    8.4 Urology Drugs Sales and Marketing
        8.4.1 Urology Drugs Sales Channels
        8.4.2 Urology Drugs Distributors
    8.5 Urology Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables Table 1. Urology Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Urology Drugs Market Trends Table 3. Urology Drugs Market Drivers Table 4. Urology Drugs Market Challenges Table 5. Urology Drugs Market Restraints Table 6. Global Urology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Urology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Urology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Urology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Urology Drugs Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Urology Drugs Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Urology Drugs Revenue Share by Manufacturer, 2017-2022 Table 13. Global Urology Drugs Sales by Manufacturer, (MT), 2017-2022 Table 14. Global Urology Drugs Sales Share by Manufacturer, 2017-2022 Table 15. Global Urology Drugs Price by Manufacturer (2017-2022) & (USD/Kg) Table 16. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2021) Table 18. Top Players of Urology Drugs in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Urology Drugs Product Type Table 20. Date of International Manufacturers Enter into Urology Drugs Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Urology Drugs Players in United States Market, Ranking by Revenue (2021) Table 23. United States Urology Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Urology Drugs Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Urology Drugs Sales by Players, (MT), 2020, 2021 & 2022 Table 26. United States Urology Drugs Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Urology Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Urology Drugs Sales in Volume by Region (2017-2022) & (MT) Table 29. Global Urology Drugs Sales in Volume Forecast by Region (2023-2028) & (MT) Table 30. Global Urology Drugs Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Urology Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Urology Drugs Sales in Volume by Country (2017-2028) & (MT) Table 33. North America Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Urology Drugs Sales in Volume by Region (2017-2028) & (MT) Table 35. Asia Pacific Urology Drugs Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Urology Drugs Sales in Volume by Country (2017-2028) & (MT) Table 37. Europe Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Urology Drugs Sales in Volume by Country (2017-2028) & (MT) Table 39. Latin Americaa Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Urology Drugs Sales in Volume by Country (2017-2028) & (MT) Table 41. Middle East and Africa Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Astellas Corporation Information Table 43. Astellas Description and Business Overview Table 44. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 45. Astellas Urology Drugs Product Table 46. Astellas Recent Development Table 47. Endo Corporation Information Table 48. Endo Description and Business Overview Table 49. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 50. Endo Product Table 51. Endo Recent Development Table 52. GP Pharm Corporation Information Table 53. GP Pharm Description and Business Overview Table 54. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 55. GP Pharm Product Table 56. GP Pharm Recent Development Table 57. Tolmar Corporation Information Table 58. Tolmar Description and Business Overview Table 59. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 60. Tolmar Product Table 61. Tolmar Recent Development Table 62. Key Raw Materials Lists Table 63. Raw Materials Key Suppliers Lists Table 64. Urology Drugs Customers List Table 65. Urology Drugs Distributors List Table 66. Research Programs/Design for This Report Table 67. Key Data Information from Secondary Sources Table 68. Key Data Information from Primary Sources List of Figures Figure 1. Urology Drugs Product Picture Figure 2. Global Urology Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Urology Drugs Market Size 2017-2028 (US$ Million) Figure 4. Global Urology Drugs Sales 2017-2028 (MT) Figure 5. United States Urology Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Urology Drugs Market Size 2017-2028 (US$ Million) Figure 7. United States Urology Drugs Sales 2017-2028 (MT) Figure 8. United States Urology Drugs Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Urology Drugs Market Share in Global, in Volume (MT) 2017-2028 Figure 10. Urology Drugs Report Years Considered Figure 11. Product Picture of ?? (alpha) Blockers Figure 12. Product Picture of 5 ??-reductase Inhibitors Figure 13. Global Urology Drugs Market Share by Type in 2022 & 2028 Figure 14. Global Urology Drugs Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Urology Drugs Sales Market Share in Value by Type (2017-2028) Figure 16. Global Urology Drugs Sales by Type (2017-2028) & (MT) Figure 17. Global Urology Drugs Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Urology Drugs Price by Type (2017-2028) & (USD/Kg) Figure 19. United States Urology Drugs Market Share by Type in 2022 & 2028 Figure 20. United States Urology Drugs Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Urology Drugs Sales Market Share in Value by Type (2017-2028) Figure 22. United States Urology Drugs Sales by Type (2017-2028) & (MT) Figure 23. United States Urology Drugs Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Urology Drugs Price by Type (2017-2028) & (USD/Kg) Figure 25. Product Picture of Hospital Figure 26. Product Picture of Clinic Figure 27. Product Picture of Others Figure 28. Global Urology Drugs Market Share by Application in 2022 & 2028 Figure 29. Global Urology Drugs Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Urology Drugs Sales Market Share in Value by Application (2017-2028) Figure 31. Global Urology Drugs Sales by Application (2017-2028) & (MT) Figure 32. Global Urology Drugs Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Urology Drugs Price by Application (2017-2028) & (USD/Kg) Figure 34. United States Urology Drugs Market Share by Application in 2022 & 2028 Figure 35. United States Urology Drugs Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Urology Drugs Sales Market Share in Value by Application (2017-2028) Figure 37. United States Urology Drugs Sales by Application (2017-2028) & (MT) Figure 38. United States Urology Drugs Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Urology Drugs Price by Application (2017-2028) & (USD/Kg) Figure 40. North America Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT) Figure 41. North America Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. U.S. Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT) Figure 45. Europe Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT) Figure 52. Asia-Pacific Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Taiwan Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Philippines Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT) Figure 64. Latin America Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Middle East & Africa Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT) Figure 69. Middle East & Africa Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Turkey Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Saudi Arabia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. U.A.E Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Urology Drugs Value Chain Figure 74. Urology Drugs Production Process Figure 75. Channels of Distribution Figure 76. Distributors Profiles Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us